E262 - The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics
Published: July 14, 2025
Duration: 54:23
We love to hear from our listeners. Send us a message.
On this week's episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering obesity-related protein receptors in the brain, how he spun his academic discoveries out into a biotech company developing new obesity drugs, the need for obesity treatments with fewer side effects than currently available GLP-1 therapies, and the value of pairing scientific leadership with a strong business partner as CEO.
This episode of the Business of Biotech is brought to you by Ecolab.